11.05.19
PLT Health Solutions, Inc. has reorganized its scientific team in order to advance its ability to support innovation at consumer product companies.
PLT veteran Barbara Davis, PhD, RD, assumes the position of head of clinical & regulatory sciences and will focus on PLT’s growing and evolving global clinical and regulatory strategy. Dr. Jeremy Appleton, ND, joins the company as director of medical & scientific affairs where he will act as a primary science resource for PLT’s U.S. customers and also actively participate in the company’s innovation strategy and marketing efforts.
Jennifer Murphy, MS, in her role as principal scientist for the company, will continue to support clinical trial development as well as focus on new product innovation and development. All three have extensive experience in the human health and nutrition field, as well as having been involved in new product development efforts for major consumer products companies.
According to Devin Stagg, COO at PLT Health Solutions, expanding the company’s science talent bench is being done in recognition of the increasing role PLT plays as an innovation partner for key customers and the importance of strong science to building compelling consumer messaging. “As our lead scientific voice for the last seven years, Barbara Davis has played a key role in PLT developing a world-class scientific capability that has helped fuel our company’s rapid growth,” he said.
According to Davis, strong clinical science—particularly as it meets the requirements of global markets—will continue to be an emphasis for PLT. “While clinical efficacy has always been at the core of our evaluation of new products, today PLT plays a far more active role in clinical development and strategy to guide the development of our solutions. We have seen that our work on best-in-class clinical trial design has enabled the success of some of our top selling ingredients,” she said.
Stagg went on to discuss the new science lineup’s ability to address innovation and new product development. “Jeremy Appleton has a singular passion for the use of natural ingredients in improving human health and happiness. His work at consumer products companies brings insight into the needs of commercial product development that will be invaluable as we work closely with our customers to help them launch exciting new products. Jen Murphy will increase her focus on new product development initiatives as PLT continues to discover and develop novel ingredient solutions for our customers. We’re extremely excited about the ability to offer such an experienced, talented group to our customers and partners,” he said.
PLT veteran Barbara Davis, PhD, RD, assumes the position of head of clinical & regulatory sciences and will focus on PLT’s growing and evolving global clinical and regulatory strategy. Dr. Jeremy Appleton, ND, joins the company as director of medical & scientific affairs where he will act as a primary science resource for PLT’s U.S. customers and also actively participate in the company’s innovation strategy and marketing efforts.
Jennifer Murphy, MS, in her role as principal scientist for the company, will continue to support clinical trial development as well as focus on new product innovation and development. All three have extensive experience in the human health and nutrition field, as well as having been involved in new product development efforts for major consumer products companies.
According to Devin Stagg, COO at PLT Health Solutions, expanding the company’s science talent bench is being done in recognition of the increasing role PLT plays as an innovation partner for key customers and the importance of strong science to building compelling consumer messaging. “As our lead scientific voice for the last seven years, Barbara Davis has played a key role in PLT developing a world-class scientific capability that has helped fuel our company’s rapid growth,” he said.
According to Davis, strong clinical science—particularly as it meets the requirements of global markets—will continue to be an emphasis for PLT. “While clinical efficacy has always been at the core of our evaluation of new products, today PLT plays a far more active role in clinical development and strategy to guide the development of our solutions. We have seen that our work on best-in-class clinical trial design has enabled the success of some of our top selling ingredients,” she said.
Stagg went on to discuss the new science lineup’s ability to address innovation and new product development. “Jeremy Appleton has a singular passion for the use of natural ingredients in improving human health and happiness. His work at consumer products companies brings insight into the needs of commercial product development that will be invaluable as we work closely with our customers to help them launch exciting new products. Jen Murphy will increase her focus on new product development initiatives as PLT continues to discover and develop novel ingredient solutions for our customers. We’re extremely excited about the ability to offer such an experienced, talented group to our customers and partners,” he said.
